Use of serine protease inhibitors in the treatment of skin diseases
US11793864B2 · kind B2 · utility
0Cited by
2References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 12, 2018 |
| Grant date | Oct 24, 2023 |
| Priority date | — |
| Expiry date | Dec 12, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to therapeutic compounds which are inhibitors of serine proteases, to pharmaceutical compositions thereof and to their use in the treatment of the human or animal body. More specifically, the present invention relates to a method for the treatment, diagnosis or prognosis of skin diseases comprising the administration to a subject in need thereof of a therapeutically effective amount of a Serine protease inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.